August 19, 2014
Eric Budish and colleagues have observed that drug companies invest significantly more in researching and developing therapies for late-stage than early-stage cancers. Their study is featured in Forbes.
Read the article >>
Get the latest Booth research on topics such as entrepreneurship, marketing, decision research, corporate governance and labor economics. Sign-up to have Capital Ideas delivered to you.
© Copyright 2004-2015 The University of Chicago Booth School of Business